VistaPharm, Inc. Recalls

Overview of recall records associated with VistaPharm, Inc., including dates, categories and classifications where available.

27recall records

Oct 14, 2020latest record date

Jul 18, 2012earliest record date

Recall history in this database

Classification mix: Class II: 21, Class III: 6.

DrugAug 29, 2012

VistaPharm Xactdose Phenytoin Oral Suspension, USP, 125mg/ 5 mL, supplied in 5 mL unit dose recall — FDA D-1658-2012

Defective container; lidding deformity allows the contained product to transpire causing potential viscosity and assay failures. The viscosity and assay failures were due to the loss of…

Class IIFDA: TerminatedVistaPharm, Inc.

DrugAug 8, 2012

VistaPharm Xactdose Phenytoin Oral Suspension, USP 125 mg/5mL, supplied in 5 mL unit dose recall — FDA D-1440-2012

Defective container; lidding deformity allows the contained product to transpire causing potential viscosity and assay failures. The viscosity and assay failures were due to the loss of…

Class IIFDA: TerminatedVistaPharm, Inc.

DrugJul 18, 2012

VistaPharm Hydrocodone Bitartrate & Acetaminophen Oral Solution 7.5 mg/325 mg per 15 mL, a) recall — FDA D-1416-2012

Impurities/Degradation Products: exceeded specification at 3 month stability testing

Class IIFDA: TerminatedVistaPharm, Inc.

Understanding this recall history

This page summarizes recall records in which the official source identifies VistaPharm, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.

Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.